European Society of Hypertension Scientific Newsletter: Clinical value of ambulatory blood pressure monitoring

Journal of Hypertension

Volumn 24, Issue 11, 2006, Pages 2327-2330

  Mallion, Jean Michel ^a   Baguet, Jean Philippe ^a   Mancia, Giuseppe ^b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG EFFICACY; HUMAN; HYPERTENSION; MEDICAL PRACTICE; MORBIDITY; NOTE; OSCILLOMETRY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 33750248919     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000249720.05006.d5     Document Type: Note

References (64)

1. O'Brien E, Petrie J, Littler WA, de Swiet M, Padfield PL, Altman D, et al. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993; 11 (Suppl 2):S43-S63.
2. Association for the Advancement of Medical Instrumentation. American national standard. Electronic or automated sphygmomanometers. Arlington, Virginia: AAMI; 1993.
3. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 2001; 322:531-536.
4. Di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension 1983; 5:269-274.
5. Villani A, Parati G, Groppelli A, Omboni S, Di Rienzo M, Mancia G. Non-invasive automatic blood pressure monitoring does not attenuate night-time hypotension, evidence from 24h intraarterial blood pressure monitoring. Am J Hypertens 1992; 5:744-747.
6. Mallion JM, De Gaudemaris R, Baguet JP, Azzouzi L, Quesada JL, Sauzeau C, et al. Acceptability and tolerance of ambulatory blood pressure measurement in hypertensive patients. Blood Press Monit 1996; 1:197-203.
7. Mancia G, Parati G. Ambulatory blood pressure monitoring and organ damage. Hypertension 2000; 36:394-399.
8. Imai Y, Ohkubo T, Sakuma M, Tsuji I, Satoh H, Nagai K, et al. Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan. Blood Press Monit 1996; 1:251-254.
9. Staessen JA, Thijs L, Fagard R, O'Brien E, Clement D, De Leeuw PW, et al. Predicting cardiovascular risk using conventional vs. ambulatory blood pressure in older patients with systolic hypertension. JAMA 1999; 282:539-546.
10. Khattar RS, Swales JD, Banfield A, Dore C, Senior R, Lahiri A. Prediction of coronary and cerebrovascular morbidity and mortality by direct continuous arterial blood pressure monitoring in essential hypertension. Circulation 1999; 100:1071-1076.
11. Robinson TG, Dawson SL, Ahmed U, Manktelow B, Fotherby MD, Potter JF. Twenty-four hour systolic blood pressure predicts long-term mortality following acute stroke. J Hypertens 2001; 19:2127-2134.
12. Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment induced regression of left ventricular hypertrophy. Circulation 1997; 95:1464-1470.
13. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al., on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21:821-848.
14. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995; 13:1377-1390.
15. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
16. Guidelines Sub-Committee. 1999 World Health Organization/International Society of Hypertension Guidelines for the management of Hypertension. J Hypertens 1999; 17:151-183.
17. Pickering TG. White-coat hypertension. Curr Opin Nephrol Hypertens 1996; 5:192-198.
18. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R, et al. Alterations of cardiac structure in patients with isolated office, ambulatory or home hypertension. Circulation 2001; 104:1385-1392.
19. Burnier M, Biollaz J, Magnin JL, Bidlingmeyer M, Brunner HR. Renal sodium handling in patients with untreated hypertension and white coat hypertension. Hypertension 1993; 23:496-502.
20. Hoegholm A, Kristensen KS, Bang LE, Nielsen JW, Nielsen WB, Madsen NH. Left ventricular mass and geometry in patients with established hypertension and white coat hypertension. Am J Hypertens 1993; 6:282-286.
21. Kuwajima I, Suzuki Y, Fujisawa A, Kuramoto K. Is white coat hypertension innocent? Structure and function of the heart in the elderly. Hypertension 1993; 22:826-831.
22. Hoegholm A, Bang LE, Kristensen KS, Nielsen JW, Holm J. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension and normotension. Hypertension 1994; 24:101-105.
23. Marchesi E, Perani G, Falaschi F, Negro C, Catalano O, Ravetta V, et al. Metabolic risk factors in white coat hypertensives. J Hum Hypertens 1994; 8:475-479.
24. Cuspidi C, Marabini M, Lonati L, Sampieri L, Comerio G, Pelizzoli S, et al. Cardiac and carotid structure in patients with established hypertension and white-coat hypertension. J Hypertens 1995; 13:1707-1711.
25. Pierdomenico SD, Lapenna D, Guglielmi MD, Antidormi T, Schiavone C, Cuccurullo F, et al. Target organ status and serum lipids in patients with white coat hypertension. Hypertension 1995; 26:801-807.
26. Glen S, Elliott H, Curzio JL, Lees KR, Reid JL. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet 1996; 348:654-657.
27. Soma J, Wideroe TE, Dahl K, Rossvoll O, Skjaerpe T. Left ventricular systolic and diastolic function assessed with two-dimensional and Doppler echocardiography in 'white coat' hypertension. J Am Coll Cardiol 1996; 28:190-196.
28. Ferrara LA, Guida L, Pasanisi F, Celentano AL, Palmieri V, Iannuzzi R, et al. Isolated office hypertension and end organ damage. J Hypertens 1997; 15:979-985.
29. Verdecchia P, Schillaci G, Borgioni C, Ciucci A. White coat hypertension: not guilty when correctly defined. Blood Press Monit 1998; 3:147-152.
30. Polonia JJ, Santos A, Gama GM, Basto F, Bettencourt P, Martins LR. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2-5 years). Blood Press Monit 1997; 2:289-295.
31. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131:564-572.
32. Wing LMH, Brown MA, Beilin LJ, Ryan P, Reid CM, on behalf of the ANBP2 Management Committee and Investigators. Reverse white-coat hypertension in older hypertensives. J Hypertens 2002; 20:639-644.
33. Bjorklund K, Lind L, Zethelius B, Andrén B, Lithell H. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003; 107:1297-1302.
34. Matsuoka S, Awazu M. Masked hypertension in children and young adults. Pediatr Nephrol 2004; 19:651-654.
35. Bjorklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens 2004; 22:1691-1697.
36. Ormezzano O, Baguet JP, François P, Quesada JL, Pierre H, Mallion JM. Is there any organ damage associated with white-coat normotension? Clin Auton Res 2004; 14:106-166.
37. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
38. Rocco MB, Nadel EG, Selvyn AP. Circadian rhythms and coronary artery disease. Am J Cardiol 1987; 59:13C-17C.
39. Muller JE. Circadian variation in cardiovascular events. Circulation 1999; 12:35S-42S.
40. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 1998; 88:397.
41. Fagard RH, Staessen JA, Thijs L. Optimal definition of daytime and night-time blood pressure. Blood Press Monit 1997; 2:315-321.
42. Omboni S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, et al. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. J Hypertens 1998; 16:733-738.
43. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27:130-135.
44. Fumo MT, Teeger S, Lang RM, Bednarz J, Sardi P, Murphy MB. Diurnal blood pressure variation and cardiac mass in American blacks and whites and South African blacks. Am J Hypertens 1992; 5:111-116.
45. O'Brien E, Atkins A, Staessen J. Are overnight dip and target organ damage related? A clinical perspective. Blood Press Monit 1996; 1 (Suppl 1):S41-S46.
46. Boley E, Pickering TG, James GD, De Simone G, Roman MJ, Devereux B. Relations of ambulatory blood pressure level and variability to left ventricular and arterial function and to left ventricular mass in normotensive and hypertensive adults. Blood Press Monit 1997; 2:323-331.
47. Pierdomenico D, Lapenna D, Guglielmi MC, Costantini F, Romano F, Schiavone C, et al. Arterial disease in dipper and non-dipper hypertensive patients. Am J Hypertens 1997; 10:511-518.
48. Roman MJ, Pickering TG, Schwartz JE, Cavallini MC, Pini RP, Devereux RB. Is the absence of a normal nocturnal fall in blood pressure (nondipping) associated with cardiovascular target organ damage? J Hypertens 1997; 15:969-978.
49. Watanabe N, Imai Y, Nagai K, Tsiji I, Satah H, Sakuma M, et al. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke 1996; 27:1319-1327.
50. Shimada K, Kario K. Altered circadian rhythm of blood pressure and cerebrovascular damage. Blood Press Monit 1997; 2:333-338.
51. Bianchi S, Bigazzi R, Campese VM. Altered circadian blood pressure profile and renal damage. Blood Press Monit 1997; 2:239-245.
52. Mancia G, Parati G, Henning M, Flatau B, Omboni S, Glavina F, et al. Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001; 19:1981-1989.
53. Mancia G, Omboni S, Ravogli A, Parati G, Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment. Additional information from a large data-base. Blood Press 1995; 4:5-11.
54. Stanton AV. The clinical relevance of extreme dipping. Blood Press Monit 1998; 3:163-166.
55. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24 hour blood pressure variability. J Hypertens 1993; 11:1133-1137.
56. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24 hour blood pressure means and variability to severity of target organ damage in hypertension. J Hypertens 1987; 5:93-98.
57. Sander D, Kukla C, Klingelhofer J. Relationship between circadian blood pressure patterns and progression of early carotid aterosclerosis: a 3 year follow-up study. Circulation 2000; 102:1536-1541.
58. Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, et al. Blood pressure variability and organ damage in a general population: results from the PAMELA Study. Hypertension 2002; 39:710-714.
59. O'Brien E, Cox JP, O'Malley K. Ambulatory pressure measurement in the evaluation of blood pressure lowering drugs [editorial review]. J Hypertens 1989; 7:243-247.
60. Coats AJS, Radaelli A, Clark SJ, Conway J, Sleight P. The influence of ambulatory blood pressure monitoring. The design and interpretation of trials in hypertension. J Hypertens 1992; 10:385-391.
61. White WB. Utilising ambulatory blood pressure recordings to evaluate antihypertensive drug therapy. Am J Cardiol 1992; 69:8E-12E.
62. Mancia G, Omboni S, Parati G. Assessment of antihypertensive treatment by ambulatory blood pressure. J Hypertens 1997; 15 (Suppl 2):543-550.
63. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens 2004; 22:435-445.
64. Parati G, Omboni S, Rizzoni D, Agabiti Rosei E, Mancia G. The smoothness index: a new reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998; 16:1685-1691.